Literature DB >> 3042002

Extracardiac rhabdomyoma: An immunocytochemical study and review of the literature.

V Eusebi1, C Ceccarelli, E Daniele, G Collina, G Viale, A M Mancini.   

Abstract

Two cases of 'adult' rhabdomyoma and 2 of 'fetal' rhabdomyoma have been immunologically studied using several antisera specific of skeletal muscle fibers proteins. This paper also deals with a review of the literature on these rare benign skeletal muscle proliferations. It is concluded that 'adult' rhabdomyoma contains fetal myosin and therefore the term 'adult' does not seem immunologically appropriate any longer. In addition the tumoral cells show the same level of differentiation as seen in neonatal skeletal muscle. Therefore it seems that the definition of neonatal rhabdomyoma is more appropriate for these benign muscular proliferations. The 2 cases of fetal rhabdomyoma appear phenotypically similar to normally developing myoblasts and contain fetal myosin. Therefore it seems that the definition 'fetal' is here appropriate for what appears to be a disorganized proliferation of otherwise normal fetal skeletal muscle fibers. The differential diagnosis between these latter tumors and rhabdomyosarcomas has been discussed.

Entities:  

Mesh:

Year:  1988        PMID: 3042002

Source DB:  PubMed          Journal:  Appl Pathol        ISSN: 0252-1172


  4 in total

1.  Adult multifocal extracardiac rhabdomyoma.

Authors:  J K Fortson; F S Prunes; A G Lang
Journal:  J Natl Med Assoc       Date:  1993-02       Impact factor: 1.798

Review 2.  Perianal fetal rhabdomyoma: case report.

Authors:  P C Lapner; S Chou; C Jimenez
Journal:  Pediatr Surg Int       Date:  1997-09       Impact factor: 1.827

Review 3.  Immunochemistry and electron microscopy of head and neck rhabdomyoma.

Authors:  T R Helliwell; M C Sissons; P J Stoney; M T Ashworth
Journal:  J Clin Pathol       Date:  1988-10       Impact factor: 3.411

4.  Extracardiac juvenile rhabdomyoma of the larynx: a rare pathological finding.

Authors:  Shachi J Sharma; Melanie Kreisel; Tobias Kroll; Stefan Gattenloehner; Jens P Klussmann; Claus Wittekindt
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-11-05       Impact factor: 2.503

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.